AI assistant
Sending…
AGENUS INC — Director's Dealing 2014
Feb 19, 2014
34023_dirs_2014-02-19_0de2d64c-280a-4735-a54b-fbe9a8da1fd7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (Agen)
CIK: 0001098972
Period of Report: 2014-02-14
Reporting Person: Wentworth Kerry (VP, CLinical, Reg, & Quality)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-14 | Stock Option, Right to Buy | $3 | A | 130000 | Acquired | 2024-02-14 | Common Stock (100000) | Direct |
Footnotes
F1: This option was awarded on 2/14/14 under the Agenus Inc. 2009 Equity Incentive Plan, as amended, ("2009 EIP") subject to forfeiture if shareholder approval of an amendment to the 2009 EIP and an amendment to the Agenus Inc. Amended and Restated Certificate of Incorporation (as amended) to increase the number of shares authorized for issuance thereunder, is not obtained at the Agenus Inc. 2014 annual shareholders' meeting. This options vests quarterly over three years beginning 5/15/14.
More from AGENUS INC
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23